|Articles|May 1, 2020
- Pharmaceutical Executive-05-01-2020
- Volume 40
- Issue 5
Pharmaceutical Executive, May 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Pharm Exec's Emerging Pharma Leaders 2020about 6 years ago
AI: Kickstarting the Race Against COVID-19about 6 years ago
Competition for Biotech CFOs is Heating Upabout 6 years ago
Biopharma Sustainability Considered Essentialabout 6 years ago
CFOs Outlook: Forging a Sustainable Futureabout 6 years ago
Drive for COVID-19 Therapies Raises Patent and Pricing Issuesabout 6 years ago
Biotech in the Age of COVID: The Pain and the Gainabout 6 years ago
A New, Less Friendly Normal Looms for European Drugmakersabout 6 years ago
How Prepared Were Doctors for the COVID Digital Upswing?about 6 years ago
Pharmaceutical Executive, May 2020 Issue (PDF)Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Pharma Patent Cliff Explained: What It Is and How Companies Navigate It
2
Roadblocks and Hurdles for DTC Prescription Drug Ad Oversight: Q&A with Dan Troy
3
FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer
4
FDA Sends CRL to Cingulate for CTx-1301
5